Results 141 to 150 of about 1,170 (185)
Some of the next articles are maybe not open access.
[Experimental and clinical pharmacokinetics of amrinone].
Cardiologia (Rome, Italy), 1982Articolo sperimentale nell'uomo circa l'amrinone, in un tempo nel quale tale farmaco era considerato avveniristico. Ampia descrizione delle sue proprietà farmacocinetiche in campo umano, con messa a punto di un metodo per la determinazione delle concentrazioni.
PADRINI, ROBERTO +4 more
openaire +2 more sources
Perioperative experience with amrinone.
European journal of anaesthesiology. Supplement, 1992Amrinone is the only phosphodiesterase fraction III inhibitor currently available in the USA for the treatment of perioperative biventricular failure. Patients with chronic congestive heart failure (CHF) show down-regulation of the beta 1-adrenergic receptor with a decrease in receptor density and altered responses to catecholamines.
J H, Levy, J M, Bailey
openaire +1 more source
Intravenous Amrinone: An Advance or a Wrong Step?
Annals of Internal Medicine, 1985Excerpt Amrinone is a nonglycosidic, non-catecholamine-dependent, inotropic vasodilator agent that has recently been made available for intravenous use in patients with severe heart failure.
openaire +2 more sources
Amrinone-induced hepatotoxicity
American Journal of Health-System Pharmacy, 1984M E, Gilman, S C, Margolis
openaire +2 more sources